ACTI — Active Biotech AB publ Share Price
Last Trade - 00:00- SEK366.28m
- SEK274.28m
- SEK6.23m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 19.04 | 20.25 | 20.05 | 8.43 | 6.72 | 9 | n/a | -16.2% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
Directors
- Michael Shalmi (55)
- Helen Tuvesson PRE (55)
- Hans Kolam (66)
- Helena Eriksson (49)
- Uli Hacksell (68)
- Peter Sjostrand (71)
- Peter Thelin (61)
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- January 1st, 1970
- Public Since
- December 1st, 1986
- No. of Employees
- 11
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 251,909,655.37
- Address
- Scheelevagen 22, LUND, 223 63
- Web
- http://www.activebiotech.com/
- Phone
- +46 46192000
- Contact
- Helen Tuvesson
- Auditors
- KPMG AB
Latest News for ACTI
Upcoming events for ACTI
Q3 2021 Active Biotech AB (publ) Earnings Release
Similar to ACTI
ABLIVA ORD
OMX Nordic Exchange Stockholm
ALZECURE PHARMA ORD
OMX Nordic Exchange Stockholm
ANNEXIN PHARMACEUTICALS ORD
OMX Nordic Exchange Stockholm
ASARINA PHARMA ORD
OMX Nordic Exchange Stockholm
BERGENBIO ORD
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:56 UTC, shares in Active Biotech AB publ are trading at SEK1.45. This share price information is delayed by 15 minutes.
Shares in Active Biotech AB publ last closed at SEK1.45 and the price had moved by -48.62% over the past 365 days. In terms of relative price strength the Active Biotech AB publ share price has underperformed the FTSE Global All Cap Index by -60.11% over the past year.
There is no consensus recommendation for this security.
Active Biotech AB publ does not currently pay a dividend.
Active Biotech AB publ does not currently pay a dividend.
Active Biotech AB publ does not currently pay a dividend.
To buy shares in Active Biotech AB publ you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK1.45, shares in Active Biotech AB publ had a market capitalisation of SEK366.28m.
Here are the trading details for Active Biotech AB publ:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ACTI
Based on an overall assessment of its quality, value and momentum Active Biotech AB publ is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Active Biotech AB publ is SEK2.52. That is 73.31% above the last closing price of SEK1.45.
Analysts covering Active Biotech AB publ currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.18 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Active Biotech AB publ. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -20.38%.
As of the last closing price of SEK1.45, shares in Active Biotech AB publ were trading -5.55% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Active Biotech AB publ.
Active Biotech AB publ's management team is headed by:
- Michael Shalmi -
- Helen Tuvesson - PRE
- Hans Kolam -
- Helena Eriksson -
- Uli Hacksell -
- Peter Sjostrand -
- Peter Thelin -
We do not have data on Active Biotech AB publ's shareholders